Respiratory news

Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care

Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care

Overuse of short-acting bronchodilator inhalers in...

Phyllocontin to be discontinued

Phyllocontin to be discontinued

Phyllocontin Continus 225mg and Phyllocontin Forte...

Third triple combination inhaler launched for COPD

Third triple combination inhaler launched for COPD

Trixeo Aerosphere is a new treatment for COPD patients,...

New LABA/LAMA combination inhaler increases choice for COPD patients

New LABA/LAMA combination inhaler increases choice for COPD patients

Bevespi Aerosphere (formoterol/glycopyrronium) is a...

First triple combination MDI licensed for asthma

First triple combination MDI licensed for asthma

Trimbow (beclometasone/formoterol/glycopyrronium) can...

New low-dose LABA/corticosteroid inhaler for asthma

New low-dose LABA/corticosteroid inhaler for asthma

A lower-dose metered-dose inhaler has been added to...

First 3-in-1 inhaler for asthma launched

First 3-in-1 inhaler for asthma launched

Enerzair Breezhaler is the first triple combination...

Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers

Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers

New research has linked oral and inhaled steroids to...

Honey 'more effective than antibiotics' for respiratory infections

Honey 'more effective than antibiotics' for respiratory infections

Honey is better than usual care for easing upper respiratory...

High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'

High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'

Frequent prescribing of short-acting ß2 agonists (SABA)...

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Asthma guidelines recommend stepping down of medication...

Delayed antibiotic prescribing for URTIs increases hospital admission risk, study shows

Delayed antibiotic prescribing for URTIs increases hospital admission risk, study shows

Delaying the prescription of antibiotics in patients...

MIMS launches Respiratory and Allergy Learning webinars

MIMS launches Respiratory and Allergy Learning webinars

Join us for the 2020 Respiratory and Allergy Learning...

NICE releases rapid guidance for primary care clinicians during COVID-19 pandemic

NICE releases rapid guidance for primary care clinicians during COVID-19 pandemic

New guidance on the care of patients with suspected...

Inhaler prescribing guidance issued as spike in demand causes shortages

Inhaler prescribing guidance issued as spike in demand causes shortages

Prescribers have been urged not to extend repeat prescription...

NICE overturns advice to increase steroid dose in children with asthma

NICE overturns advice to increase steroid dose in children with asthma

NICE has withdrawn its recommendation to quadruple...

Free respiratory and allergy workshops announced

Free respiratory and allergy workshops announced

The MIMS Workshops Respiratory and Allergy Learning...

PHE issues coronavirus guidance for primary care

PHE issues coronavirus guidance for primary care

Public Health England (PHE) has issued guidance for...

Triple therapy 'potentially best option' for stable COPD patients

Triple therapy 'potentially best option' for stable COPD patients

Triple therapy with a long-acting muscarinic antagonist...

MHRA advises prescribers to consider carefully the benefits and neuropsychiatric risks of montelukast

MHRA advises prescribers to consider carefully the benefits and neuropsychiatric risks of montelukast

Prescribers should be alert for possible neuropsychiatric...